UA55369C2 - Пептид і фармацевтична композиція, що здатні інгібувати секрецію пепсину - Google Patents

Пептид і фармацевтична композиція, що здатні інгібувати секрецію пепсину Download PDF

Info

Publication number
UA55369C2
UA55369C2 UA96103911A UA96103911A UA55369C2 UA 55369 C2 UA55369 C2 UA 55369C2 UA 96103911 A UA96103911 A UA 96103911A UA 96103911 A UA96103911 A UA 96103911A UA 55369 C2 UA55369 C2 UA 55369C2
Authority
UA
Ukraine
Prior art keywords
rgo
fact
peptide according
peptide
aia
Prior art date
Application number
UA96103911A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Монік ДЕКРУА-ВАНЬ
Даніель ПАНСЮ
Тьєрі ТАРРАД
Original Assignee
Сосьєте Де Консей Де Решерш Е Даплікасьон Сьєнтіфік (С.К.Р.А.С.)
Інстітьют Насьональ Де Ля Сант Е Де Ля Решерш Медікаль (Інсерм)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сосьєте Де Консей Де Решерш Е Даплікасьон Сьєнтіфік (С.К.Р.А.С.), Інстітьют Насьональ Де Ля Сант Е Де Ля Решерш Медікаль (Інсерм) filed Critical Сосьєте Де Консей Де Решерш Е Даплікасьон Сьєнтіфік (С.К.Р.А.С.)
Publication of UA55369C2 publication Critical patent/UA55369C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
UA96103911A 1994-03-16 1995-03-14 Пептид і фармацевтична композиція, що здатні інгібувати секрецію пепсину UA55369C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9405162A GB9405162D0 (en) 1994-03-16 1994-03-16 Heptapeptides
PCT/FR1995/000296 WO1995025123A1 (fr) 1994-03-16 1995-03-14 Peptides pour inhiber la liberation de pepsine

Publications (1)

Publication Number Publication Date
UA55369C2 true UA55369C2 (uk) 2003-04-15

Family

ID=10751970

Family Applications (1)

Application Number Title Priority Date Filing Date
UA96103911A UA55369C2 (uk) 1994-03-16 1995-03-14 Пептид і фармацевтична композиція, що здатні інгібувати секрецію пепсину

Country Status (31)

Country Link
US (1) US5668109A (de)
EP (1) EP0750635B1 (de)
JP (1) JP3109835B2 (de)
KR (1) KR100359713B1 (de)
CN (1) CN1070865C (de)
AP (1) AP546A (de)
AT (1) ATE174037T1 (de)
AU (1) AU694476B2 (de)
BR (1) BR9507063A (de)
CA (1) CA2144569A1 (de)
DE (1) DE69506390T2 (de)
DK (1) DK0750635T3 (de)
DZ (1) DZ1865A1 (de)
ES (1) ES2127516T3 (de)
FI (1) FI963615A7 (de)
FR (2) FR2717391B1 (de)
GB (2) GB9405162D0 (de)
GR (1) GR3029513T3 (de)
IE (1) IE950192A1 (de)
MA (1) MA23481A1 (de)
NO (1) NO316802B1 (de)
NZ (1) NZ270704A (de)
OA (1) OA10136A (de)
PL (1) PL180672B1 (de)
RO (1) RO112729B1 (de)
RU (1) RU2144038C1 (de)
TN (1) TNSN95019A1 (de)
TW (1) TW380141B (de)
UA (1) UA55369C2 (de)
WO (1) WO1995025123A1 (de)
ZA (1) ZA951923B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405162D0 (en) * 1994-03-16 1994-04-27 Scras Heptapeptides
TW201318665A (zh) * 2011-11-03 2013-05-16 San Huei United Co Ltd 摺疊式之立體口罩

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971736A (en) * 1975-01-21 1976-07-27 Merck & Co., Inc. Cathepsin in D inhibitors
US5276016A (en) * 1986-06-03 1994-01-04 The United States Of America As Represented By The Department Of Health And Human Services Small peptides which inhibit binding to T-4 receptors and act as immunogens
FR2601020B1 (fr) * 1986-07-03 1989-05-12 Inst Nat Sante Rech Med Sorbine purifiee, nouveaux peptides ayant des sequences peptidiques en commun avec la sorbine et compositions pharmaceutiques les contenant
JP2793216B2 (ja) * 1988-01-08 1998-09-03 インスティチュート・ナショナル・ドゥ・ラ・サンテ・エ・ドゥ・ラ・ルシェルシェ・メディカル 粘膜による吸収を高める、ソルビン及び誘導ペプチド
PT93320B (pt) * 1990-03-02 1996-07-31 Univ Tulane Processo para a preparacao de peptideos terapeuticos
GB9405162D0 (en) * 1994-03-16 1994-04-27 Scras Heptapeptides

Also Published As

Publication number Publication date
GB2287942A (en) 1995-10-04
GB9504733D0 (en) 1995-04-26
DE69506390D1 (de) 1999-01-14
AU1487095A (en) 1995-09-28
GR3029513T3 (en) 1999-05-28
FR2717390B1 (fr) 1996-05-31
ZA951923B (de) 1995-12-11
JPH09512787A (ja) 1997-12-22
KR100359713B1 (ko) 2003-01-15
DZ1865A1 (fr) 2002-02-17
EP0750635A1 (de) 1997-01-02
NO963856D0 (no) 1996-09-13
ATE174037T1 (de) 1998-12-15
AP9500724A0 (en) 1995-04-30
US5668109A (en) 1997-09-16
DK0750635T3 (da) 1999-08-16
RU2144038C1 (ru) 2000-01-10
JP3109835B2 (ja) 2000-11-20
OA10136A (fr) 1996-12-18
FR2717390A1 (fr) 1995-09-22
TW380141B (en) 2000-01-21
AU694476B2 (en) 1998-07-23
PL316288A1 (en) 1997-01-06
FR2717391B1 (fr) 1996-05-31
DE69506390T2 (de) 1999-07-01
FI963615A0 (fi) 1996-09-13
NO316802B1 (no) 2004-05-18
TNSN95019A1 (fr) 1996-02-06
KR970701732A (ko) 1997-04-12
MA23481A1 (fr) 1995-10-01
AP546A (en) 1996-10-29
MX9603991A (es) 1997-09-30
FR2717391A1 (fr) 1995-09-22
CN1070865C (zh) 2001-09-12
EP0750635B1 (de) 1998-12-02
GB2287942B (en) 1997-07-16
FI963615L (fi) 1996-09-13
PL180672B1 (pl) 2001-03-30
RO112729B1 (ro) 1997-12-30
NO963856L (no) 1996-09-13
GB9405162D0 (en) 1994-04-27
ES2127516T3 (es) 1999-04-16
WO1995025123A1 (fr) 1995-09-21
CN1143968A (zh) 1997-02-26
IE950192A1 (en) 1995-09-20
FI963615A7 (fi) 1996-09-13
BR9507063A (pt) 1997-09-02
CA2144569A1 (en) 1995-09-17
NZ270704A (en) 1996-05-28

Similar Documents

Publication Publication Date Title
RU2165432C2 (ru) Новые опиоидоподобные пептиды, способ их получения, фармацевтическая композиция
NZ202297A (en) Peptide derivatives and pharmaceutical compositions
EA020005B1 (ru) Аналоги глюкозазависимого инсулинотропного полипептида
EP0813544A1 (de) Bradykinin-antagonist peptide mit n-substituierten glycinen
UA34456C2 (uk) Пептид, який має активність антагоніста бомбезину, фармацевтична композиція на його основі і спосіб лікування раку у ссавців
US5786335A (en) Sulfhydryl containing peptides for treating vascular disease
Hardy et al. Peripherally acting enkephalin analogs. 1. Polar pentapeptides
UA55369C2 (uk) Пептид і фармацевтична композиція, що здатні інгібувати секрецію пепсину
US4713367A (en) Retro-inverso analogs of the bradykinin potentiating peptide BPP5a
WO1995024421A1 (en) Peptide derivative
KR19990044553A (ko) 펩티드 유도체
MXPA96003991A (en) Peptides to inhibit the release of peps
EP0190597A2 (de) Retro-Inverso-Analoga von Peptid BPP5a mit Bradykinin-Wirkung
KR101019246B1 (ko) 역순 광학 이성체 펩티드를 포함하는 약제학적 조성물
JPS61271300A (ja) 新規ペプチド
NL8900882A (nl) Peptidederivaten, werkwijzen voor hun bereiding en farmaceutische preparaten die ze bevatten.
HU224494B1 (hu) A pepszin felszabadulását gátló peptidek és e vegyületeket tartalmazó gyógyszerkészítmények
JPH07116234B2 (ja) 新規ペプチド
MXPA98001192A (en) New opioid peptides
JPH07149793A (ja) 新規ペプチド
JPH07300496A (ja) ペプチド誘導体
JPH083190A (ja) 細胞接着活性コア配列の繰り返し構造からなるポリペプチド